Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Valneva initiated with a Buy at Jefferies » 08:23
06/01/21
06/01
08:23
06/01/21
08:23
VALN

Valneva

$25.62 /

+0.735 (+2.95%)

Jefferies analyst Maury…

Jefferies analyst Maury Raycroft initiated coverage of Valneva with a Buy rating and $36 price target. The company has three vaccine candidates in late-stage development along with a commercial base business, noted Raycroft, who thinks Valneva's history in the EU gives it "a low-profile perception" that creates an opportunity for U.S. investors. He calls out phase 3 data for chikungunya due in mid 2021 and results for the company's inactivated COVID-19 vaccine as upcoming catalysts with "upside potential."

ShowHide Related Items >><<
VALN Valneva
$25.62 /

+0.735 (+2.95%)

06/01/21 Goldman Sachs
Valneva initiated with a Buy at Goldman Sachs
05/31/21 Guggenheim
Valneva initiated with a Buy at Guggenheim
  • 07
    May
Initiation
Valneva initiated with a Buy at Goldman Sachs » 05:01
06/01/21
06/01
05:01
06/01/21
05:01
VALN

Valneva

$25.62 /

+0.735 (+2.95%)

Goldman Sachs analyst…

Goldman Sachs analyst Graig Suvannavejh initiated coverage of Valneva with a Buy rating and $34 price target. Valneva is a French specialty vaccines company, with a portfolio that consists of two approved products, Dukoral for cholera and Ixiaro for Japanese encephalitis virus, as well as an emerging pipeline, Suvannavejh tells investors in a research note. The analyst views VLA15 as a "unique opportunity," given that there are no Lyme disease vaccines on the market.

ShowHide Related Items >><<
VALN Valneva
$25.62 /

+0.735 (+2.95%)

05/31/21 Guggenheim
Valneva initiated with a Buy at Guggenheim
  • 07
    May
Initiation
Valneva initiated with a Buy at Guggenheim » 12:58
05/31/21
05/31
12:58
05/31/21
12:58
VALN

Valneva

$25.62 /

+0.735 (+2.95%)

Guggenheim analyst Dana…

Guggenheim analyst Dana Flanders initiated coverage of Valneva with a Buy rating and $35 price target.

ShowHide Related Items >><<
  • 07
    May
Over a month ago
Syndicate
Valneva opens at $30.47, IPO priced at $26.41 » 09:37
05/07/21
05/07
09:37
05/07/21
09:37
VALN

Valneva

$28.41 /

+1.36 (+5.03%)

Valneva (VALN) priced…

Valneva (VALN) priced 3.5M shares at $26.41. Goldman Sachs acted as lead book running manager for the offering.

ShowHide Related Items >><<
  • 07
    May
Syndicate
Valneva 3.5M share IPO priced at $26.41 » 06:37
05/06/21
05/06
06:37
05/06/21
06:37
VALN

Valneva

/

+

Goldman Sachs acted as…

Goldman Sachs acted as lead book running manager for the offering.

ShowHide Related Items >><<
  • 07
    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.